Green Gruff Inc. – Trademark Portfolio

Entity Type: 03

Green Gruff Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 31 (Natural Agricultural Products) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GRUFFIES and GREEN GRUFF. The owner is based in Toronto Ontario.

604 - 55 Prince Arthur Avenue

Toronto Ontario M5R1B3 , CA

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Green Gruff Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

31
Natural Agricultural Products (7 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

Frequently Asked Questions

How many trademarks does Green Gruff Inc. have?

Green Gruff Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 3 registered, 8 abandoned.

What trademark classes does Green Gruff Inc. file in?

Green Gruff Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Green Gruff Inc.'s most well-known trademarks?

Green Gruff Inc.'s registered trademark portfolio includes well-known marks such as GRUFFIES and GREEN GRUFF. These are among 3 currently registered trademarks in the portfolio.

What is Green Gruff Inc.'s trademark registration success rate?

Green Gruff Inc. has a 27% trademark registration rate, with 3 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.